Enveric Biosciences (ENVB) to Release Quarterly Earnings on Monday

Enveric Biosciences (NASDAQ:ENVBGet Free Report) will likely be issuing its quarterly earnings data before the market opens on Monday, March 24th. Analysts expect the company to announce earnings of ($6.00) per share for the quarter.

Enveric Biosciences Stock Up 5.5 %

Shares of ENVB opened at $1.73 on Monday. The stock’s fifty day simple moving average is $3.13 and its 200-day simple moving average is $5.23. The firm has a market capitalization of $1.17 million, a PE ratio of -0.05 and a beta of 0.47. Enveric Biosciences has a 12-month low of $1.13 and a 12-month high of $28.05.

Wall Street Analyst Weigh In

Separately, HC Wainwright reiterated a “buy” rating and issued a $10.00 price objective on shares of Enveric Biosciences in a report on Thursday, March 6th.

View Our Latest Report on Enveric Biosciences

Enveric Biosciences Company Profile

(Get Free Report)

Enveric Biosciences, Inc, a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health.

Featured Stories

Earnings History for Enveric Biosciences (NASDAQ:ENVB)

Receive News & Ratings for Enveric Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enveric Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.